Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	98.04	37.80	19.09
Graham Fair Price	-27.10	13.73	18.83
PEG	-32.06	-1.37	-1.04
Price/Book	24.20	3.17	2.55
Price/Cash Flow	-81.05	27.10	-143.00
Prices/Earnings	129.71	64.13	27.92
Price/Sales	18.00	4.53	3.84
Price/FCF	-81.05	27.10	-143.00
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-1.94	0.25	0.26
Operating Margin	-31.11	0.04	0.06
ROA	-49.31	< 0.005	< 0.005
ROE	0.02	0.01	-45.93
ROIC	0.02	< 0.005	-46.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.01	-44.72
Dividends QOQ	-1.00	-0.20	80.20
EBIT QOQ	-0.11	-0.28	-148.20
EPS QOQ	-0.27	-0.47	-73.94
FCF QOQ	-1.42	7.50	428.06
Revenue QOQ	-0.03	0.04	28.99
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.18	67.04	-14.24
Days Sales Outstanding (DSO)	67.34	54.14	-19.59
Inventory Turnover	1.15	1.34	16.61
Debt/Capitalization	0.37	0.29	-23.09
Quick Ratio	0.91	0.90	-1.90
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	26.27	26.04	-0.86
Cash	9.31	10.71	14.99
Capex	-1.51	-0.06	96.21
Free Cash Flow	-0.47	3.04	549.65
Revenue	17.44	18.20	4.35
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.37	1.40	1.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.97	0.74	-23.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating